Telomerase activation in colorectal carcinogenesis

Journal of Pathology

Volumn 189, Issue 2, 1999, Pages 207-212

  Yan, Pu ^b   Saraga, Emilia P ^b   Bouzourene, Hanifa ^b   Bosman, Fred T ^b   Benhattar, Jean ^a,b  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Colorectal adenoma; Colorectal carcinoma; K ras mutation; P53 mutation; Telomerase; TRAP assay

Indexed keywords

PROTEIN P53; RIBOSOME RNA; TELOMERASE;

ADENOMA; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; DYSPLASIA; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE K RAS; PRIORITY JOURNAL; RNA DEGRADATION;

ADENOMA; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENES, P53; GENES, RAS; HUMANS; MUTATION; NEOPLASM PROTEINS; TELOMERASE;

EID: 0032882705     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199910)189:2<207::AID-PATH424>3.0.CO;2-H     Document Type: Article

References (36)

1. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
2. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 1996; 18: 173-179.
3. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56: 645-650.
4. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711-3715.
5. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082-9086.
6. Chiu CP, Dragowska W, Kim NW. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996; 14: 239-248.
7. Tailor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyzsek MA, Shay JW. Telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996; 106: 759-765.
8. Harle-Bachor C, Boukamp P. Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Nail Acad Sci U S A 1996; 93: 6476-6481.
9. Hiyama E, Hiyama K, Tatsumoto N, Shay JW, Yokoyama T. Telomerase activity in human intestine. Int J Oncol 1996; 9: 453-458.
10. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-573.
11. Greider C. Mammalian telomere dynamics: healing, fragmentation, shortening and stabilization. Curr Opin Genet Dev 1994; 4: 203-211.
12. Watson JD. Origin of concatameric T7 DNA. Nature New Biol 1972; 239: 197-201.
13. Morin GB. The human telomerase terminal transferase enzyme is a ribo-nucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59: 521-529.
14. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955-959.
15. Shay JW, Bacchetti SA. Survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-791.
16. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
17. Taraha H, Kuniyasu H, Yokozaki H, Yasui W, Ide T, Tahara E. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995; 1: 1245-1251.
18. Chadeneau C, Hay K, Hirte HW, Gallinger S, Bacchetti S. Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2533-2536.
19. Meeker AK, Coffey DS. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry 1997; 62: 1323-1331.
20. Saraga E, Bautista D, Dorta G, et al. Genetic heterogeneity in sporadic colorectal adenomas. J Pathol 1997; 181: 281-286.
21. Wright WE, Shay JW, Piatysrek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995; 23: 3794-3795.
22. Yan P, Bosman FT, Benhattar J. Tissue quality is an important determinant of telomerase activity as measured by the TRAP assay. Biotechniques 1998; 25: 660-662.
23. Jass JR, Sobin LH. Histological typing of intestinal tumors. In: WHO International Histological Classification of Tumors. 2nd edn. Berlin: Springer-Verlag, 1989.
24. O'Brein MJ, Winawer SJ, Zauber AG, et al. The National Polyp Study: patients and characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology 1990; 98: 371-379.
25. Zhang JS, Caplin S, Bosman FT, Benhattar J. Genetic diversity at the p53 locus between primary human colorectal adenocarcinomas and their lymphnode metastases. Int J Cancer 1997; 70: 674-678.
26. Kyo S, Takakura M, Tanaka M, et al. Quantitative differences in telomerase activity among malignant, premalignant, and benign ovarian lesions. Clin Cancer Res 1998; 4: 399-405.
27. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 2: 799-803.
28. Mao L, El-Naggar AK, Fan YH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 1996; 56: 5600-5604.
29. Yashima K, Litzky LA, Kaiser L, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997; 57: 2372-2377.
30. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey S. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56: 218-222.
31. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nature Med 1997; 3: 1271-1274.
32. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87: 159-170.
33. Bos JL, Fearon ER, Hamilton SR, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293-297.
34. Forester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human carcinogenesis. Nature 1987; 327: 298-303.
35. Baker SJ, Presinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990; 50: 7717-7722.
36. Goh HS, Chan CS, Khine K, Smith DR. p53 and behaviour of colorectal cancer. Lancet 1994; 344: 233-234.